FDA Says ADHD Med Adderall Is in Short Supply
THURSDAY, Oct. 13, 2022 (HealthDay News) — People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday.The Adderall and …
Learn MoreThiazolidinedione Monotherapy for T2DM Tied to Lower Dementia Risk
WEDNESDAY, Oct. 12, 2022 (HealthDay News) — For patients with type 2 diabetes (T2D), thiazolidinedione (TZD) monotherapy is associated with reduced dementia risk compared with metformin (MET) monotherapy, while sulfonylurea (SU) monotherapy is associ…
Learn More¿Cirugías de rodilla u hombros sin opioides? Un estudio encuentra que es posible
LUNES, 10 de octubre de 2022 (HealthDay News) — Mientras los políticos y las autoridades de salud buscan soluciones para una epidemia de opioides que acaba con las vidas de decenas de miles de personas cada año, los médicos que recetan los analgésico…
Learn MoreCefepime/Enmetazobactam Noninferior for Complicated UTI
TUESDAY, Oct. 11, 2022 (HealthDay News) — For patients with complicated urinary tract infection (UTI) or acute pyelonephritis caused by gram-negative pathogens, cefepime/enmetazobactam is noninferior and superior to piperacillin/tazobactam for clinic…
Learn MoreLenabasum Studied for Refractory Cutaneous Dermatomyositis
TUESDAY, Oct. 11, 2022 (HealthDay News) — Lenabasum is well tolerated for the treatment of amyopathic dermatomyositis, according to a phase 2 study published online Oct. 1 in the Journal of Investigative Dermatology.Victoria P. Werth, M.D., from the …
Learn MoreOrder of Radiation Sickness Drug Unrelated to Recent Events in Ukraine
TUESDAY, Oct. 11, 2022 (HealthDay News) — While the United States has recently ordered a $290 million supply of a drug meant to treat radiation sickness, federal health officials say that is not cause for alarm.It is coincidental that the order of Np…
Learn MoreKnee, Shoulder Surgeries Without Opioids? It’s Possible, Study Finds
MONDAY, Oct. 10, 2022 (HealthDay News) — While politicians and health officials seek solutions to an opioid epidemic that kills tens of thousands every year, doctors who prescribe the pain medications are seeking alternatives for their patients.New r…
Learn MoreTelmisartan Does Not Improve Six-Minute Walk Distance in PAD
FRIDAY, Oct. 7, 2022 (HealthDay News) — For patients with lower-extremity peripheral artery disease (PAD), telmisartan does not improve six-minute walk distance compared with placebo at six-month follow-up, according to a study published in the Oct. …
Learn MoreTreatments Compared for Pediatric-Onset Multiple Sclerosis
THURSDAY, Oct. 6, 2022 (HealthDay News) — More patients with pediatric-onset multiple sclerosis (POMS) are free of new or newly enlarging (N or NE) T2 hyperintense lesions with dimethyl fumarate (DMF) versus interferon β-1a (IFNβ-1a) treatment, and t…
Learn MoreEs menos probable que los pacientes de las minorías reciban los fármacos más recientes para el Alzheimer
MARTES, 4 de octubre de 2022 (HealthDay News) — Aunque ciertos grupos minoritarios tienen más probabilidades de recibir un diagnóstico de demencia que sus contrapartes blancas, quizá también sea menos probable que sean elegibles para los nuevos trata…
Learn More